Age is the biggest risk factor for Alzheimer’s. Approximately 10 percent of people over the age of 65 develop the disease. And for most of

Scientists have linked the progression of Alzheimer’s to the buildup of specific proteins in the brain. One of the best-known of these Alzheimer’s biomarker proteins

Is there any surefire way to prevent Alzheimer’s diease? Data published in The Lancet found that as many as 40 percent of dementia cases are

The stigma surrounding dementia has decreased in recent years, but there are still a lot of myths and misinformation making the rounds online.  Dementia is

People diagnosed with cancer are less likely to develop dementia. This strange relationship between these two diseases may help reveal a dementia treatment. Dementia is

Symptom management in Alzheimer’s helps people remain independent for longer.  Alzheimer’s disease is a progressive neurodegenerative condition affecting more than one in every nine Americans

Dementia is a complex condition with no singular cause — it doesn’t stem from one single lifestyle decision, and it isn’t an inevitable symptom of

Your phone rings out of the blue. It’s an unknown number. Picking up, you hear a gruff, aggressive voice on the other end. They tell

Frequent falls may be a sign of something more serious. Cognitive testing could help rule out brain health problems. As people age, they may begin

Experts share why everyone might have different sleeping needs, along with guidance on overcoming insomnia.  Do you know if you’re getting enough sleep?  Scientists have

“A lot of the new thinking is, if it’s good for your heart, it’s good for your brain,” says Dr. Gregory Jicha, a neurology professor

Amyloid plaques are a hallmark of Alzheimer’s disease. The interesting thing is, not everyone who develops these plaques gets Alzheimer’s. Answering this question could reveal

The brain’s power generators, mitochondria, could hold the key to Alzheimer’s disease. Understanding them better is also shedding light on the potential of diabetes drugs

K2 Medical Research is recruiting for a Phase 2 trial of Alector and Abbvie’s new experimental Alzheimer’s drug, AL002.  K2 is screening possible trial participants

Long-term care homes are looking for new ways to improve the lives of their residents. Using dogs and dog robots, scientists have found an unlikely

By: Simon Spichak With all the seemingly contradictory headlines, it is hard to tell whether coffee is good or bad for you. This article explores

K2 Med is recruiting for a new Phase 3 trial for Eli Lilly’s new Alzheimer’s drug donanemab. By: Simon Spichak K2 is screening possible trial

When it comes to music and the brain, there is a very special link. By: Simon Spichak When Tony Bennett’s family announced last February that

K2 is recruiting for a new Phase 3 trial for Alzheon’s new drug, which aims to be the first oral disease-modifying therapy for Alzheimer’s. Join

Alzheimer’s kills brain cells. Can we help the brain make new ones? By: Simon Spichak If you scrape your knee or break a bone, new